BCG Vaccine Market Size Poised to Hit USD 74.26 Million by 2030, Driven by a 4.8% CAGR, Says AMR
Allied Market Research published a report, titled, "๐๐๐ ๐๐๐๐๐ข๐ง๐ ๐๐๐ซ๐ค๐๐ญ ๐๐ฒ ๐๐๐ฆ๐จ๐ ๐ซ๐๐ฉ๐ก๐ข๐๐ฌ (๐๐๐๐ข๐๐ญ๐ซ๐ข๐ (๐-๐๐ ๐๐๐๐ซ๐ฌ) ๐๐ง๐ ๐๐๐ฎ๐ฅ๐ญ๐ฌ (๐๐-๐๐ ๐๐๐๐ซ๐ฌ): ๐๐ฅ๐จ๐๐๐ฅ ๐๐ฉ๐ฉ๐จ๐ซ๐ญ๐ฎ๐ง๐ข๐ญ๐ฒ ๐๐ง๐๐ฅ๐ฒ๐ฌ๐ข๐ฌ ๐๐ง๐ ๐๐ง๐๐ฎ๐ฌ๐ญ๐ซ๐ฒ ๐ ๐จ๐ซ๐๐๐๐ฌ๐ญ, ๐๐๐๐-๐๐๐๐."The report provides a detailed analysis of the top investment pockets, top winning strategies, drivers & opportunities, market size & estimations, competitive landscape, and evolving market trends. The market study is a helpful source of information for the frontrunners, new entrants, investors, and shareholders in crafting strategies for the future and heightening their position in the market.BCG Vaccine Market Size was Valued at USD 46.63 Million in 2020 and is Anticipated to Garner USD 74.26 Million by 2030, registering a CAGR of 4.8% from 2021 to 2030.
Rise in prevalence of tuberculosis, especially in developing and underdeveloped countries, and technological advancement in the field of vaccine research drive the growth of the global BCG vaccine market. On the other hand, certain side effects and global shortage of the vaccine impede the growth to some extent. However, untapped market opportunities in developing economies have been highly beneficial for the market growth.
๐๐๐ญ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐๐ ๐๐๐ฉ๐จ๐ซ๐ญ ๐ฐ๐ข๐ญ๐ก ๐๐ซ๐๐ฉ๐ก๐ฌ ๐๐ง๐ ๐ ๐ข๐ ๐ฎ๐ซ๐๐ฌ ๐๐๐ซ๐: https://www.alliedmarketresearch.com/request-sample/4419
๐๐จ๐ฉ ๐๐จ๐ฆ๐ฉ๐๐ง๐ข๐๐ฌ ๐๐ ๐๐๐ ๐๐๐๐๐ข๐ง๐๐ฌ
โข AJ Biologics
โข China National group corporation (Sinopharm)
โข Greensignal Biopharma Limited
โข Intervax Ltd.
โข Japan BCG Laboratory
โข Merck & Co., Inc.
โข Sanofi
โข Serum Institute of India Pvt. Ltd.
โข Stetens Serum Institute
โข Torlak Institute of Virology
๐๐๐ ๐๐๐๐๐ข๐ง๐๐ฌ ๐๐ง๐๐ฎ๐ฌ๐ญ๐ซ๐ฒ ๐๐๐ ๐ฆ๐๐ง๐ญ๐๐ญ๐ข๐จ๐ง
By demographics, the pediatrics segment generated the highest share in 2020, holding more than three-fourths of the global BCG vaccine market. The same segment is also expected to cite the fastest CAGR of 5.0% from 2021 to 2030, owing to an increase in the prevalence of tuberculosis, especially in developing and underdeveloped countries, and technological advancements in the field of vaccine research.
By region, Asia-Pacific contributed to the major market share in terms of revenue in 2020, holding nearly two-fifths of the global BCG vaccine market. The same region is also projected to cite the fastest CAGR of 5.3% from 2021 to 2030. This is attributed to improvements in healthcare infrastructure, rise in the number of hospitals equipped with advanced medical facilities, and developments in the R&D sector in the region
๐๐ฎ๐ซ๐๐ก๐๐ฌ๐ ๐ญ๐ก๐ ๐๐๐ฉ๐จ๐ซ๐ญ: https://www.alliedmarketresearch.com/purchase-enquiry/4419
Our Market Research Solution Provides You Answer to Below Mentioned Question:
โข Which are the driving factors responsible for the growth of market?
โข Which are the roadblock factors of this market?
โข What are the new opportunities, by which market will grow in coming years?
โข What are the trends of this market?
โข Which are main factors responsible for new product launch?
โข How big is the global & regional market in terms of revenue, sales and production?
โข How far will the market grow in forecast period in terms of revenue, sales and production?
โข Which region is dominating the global market and what are the market shares of each region in the overall market in 2022?
โข How will each segment grow over the forecast period and how much revenue will these segments account for in 2030?
โข Which region has more opportunities?
By Region Outlook
โข North America
(U.S., Canada, Mexico)
โข Europe
(Germany, France, UK, Italy, Spain, Rest of Europe)
โข Asia-Pacific
(Japan, China, India, Rest of Asia-Pacific)
โข LAMEA
(Brazil, Saudi Arabia, South Africa, Rest of LAMEA)
Contact Details:
David Correa
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
help@alliedmarketresearch.com
About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release BCG Vaccine Market Size Poised to Hit USD 74.26 Million by 2030, Driven by a 4.8% CAGR, Says AMR here
News-ID: 3482600 • Views: โฆ
More Releases from Allied Market Research (AMR)
Artificial Joints Market Size (USD 31.8 billion by 2032) Growing Rapidly with Re โฆ
Allied Market Research published a report, titled,โฏ"Artificial Joints Market by Type (Cemented Artificial Joints and Non-cemented Artificial Joints), Application (Artificial Knee Joints, Artificial Hip Joints, and Others), Material (Ceramics, Alloy, and Others), and End User (Hospitals and Others): Global Opportunity Analysis and Industry Forecast, 2023-2032."โฏAccording to the report, the global artificial Joints industry was valued at USD 20.2 billion in 2022 and is projected to reach USD 31.8 billion byโฆ
U.S. Contrast Injector Systems Market Size (USD 693.70 Million Revenue by 2032) โฆ
Contrast injector system is a medical diagnostic device that uses a contrast medium to create visual representations of the interior of human body to diagnose, monitor, or treat clinical problems. Contrast media is preferred over conventional image processing, as it improves the contrast structures or visibility of fluids within the body. It is utilized to make blood vessels and the gastrointestinal tract more visible.
Allied Market Research has published a studyโฆ
U.S. Healthcare IT Market Size (USD 344.07 billion Revenue by 2030) Growing Rapi โฆ
Allied Market Research published a report, titled, "U.S. Healthcare IT Market By Product Type (Healthcare Provider Solutions, Healthcare Payer Solutions, and HCIT Outsourcing Services) and End User (Healthcare Providers and Healthcare Payers): Opportunity Analysis and Industry Forecast, 2021-2030." According to the report, the U.S. Healthcare IT Market Size was valued at USD 96.93 billion in 2020 and it is estimated to surpass around USD 344.07 billion by 2030, with aโฆ
Battery Swapping Market Growth, Competitive Analysis, Prospects, And Top Key Pla โฆ
The battery swapping market size was valued at $120.3 million in 2022, and battery swapping industry is estimated to reach $642.7 million by 2032, growing at a CAGR of 18.3% from 2023 to 2032.
Battery swapping is a place at which an electric vehicle's discharged battery or battery pack may be immediately swapped for a fully charged one, eliminating the delay involved in waiting for a vehicle's battery to charge. Batteryโฆ
More Releases for BCG
BCG Vaccine Market Swot Analysis by key players Merck, Sanofi Pasteur, Japan BCG โฆ
BCG Vaccine Market Status and Trend Analysis 2017-2026 (COVID-19 Version) is latest research study released by HTF MI evaluating the market, highlighting opportunities, risk side analysis, and leveraged with strategic and tactical decision-making support. The study provides information on market trends and development, drivers, capacities, technologies, and on the changing investment structure of the BCG Vaccine Market. Some of the key players profiled in the study are Merck, Sanofi Pasteur,โฆ
BCG Vaccine Market: Development Factors and Investment Analysis by Leading Manuf โฆ
LOS ANGELES, United States 2020: This BCG Vaccine market report work with respect to opportunities, challenges, drivers, market structures, and competitive landscape for the clients. The report is a complete overview of the market, covering various aspects including product definition, market segmentation based on various parameters, and the prevailing vendor landscape. The report is helpful to present you better solutions in terms of product trends, future products, marketing strategy, futureโฆ
BCG Vaccine Booming Segments; Investors Seeking Growth | Sanofi Pasteur, Japan B โฆ
Latest Research Study on Global BCG VaccineMarket published by AMA, offers a detailed overview of the factors influencing the global business scope.Global BCG Vaccine Market research report shows the latest market insights with upcoming trends and breakdown of the products and services.The report provides key statistics on the market status, size, share, growth factors, Challenges and Current Scenario Analysis of the Global BCG Vaccine.This Report also covers the emerging player'sโฆ
Global Freeze-Dried BCG Vaccine Market 2020 - Merck, Sanofi Pasteur (Sanofi), Ja โฆ
Goble Freeze-Dried BCG Vaccine Market 2020, Market Size Value CAGR (USD Million)and revenue ($$$) for the historical period (2016 - 19) and projected years (2020 - 26), SWOT, Industry, Sales, Demand, Analysis, Opportunities and Forecast to 2026 All Cover in This Report
Freeze-Dried BCG Vaccine
View Detailed Report at @ http://www.marketresearchstore.com/report/global-freeze-dried-bcg-vaccine-market-professional-survey-618056
Market study on most trending report Global global Freeze-Dried BCG Vaccine Market 2020 Industry Research Report detailed information onโฆ
BCG Vaccines Sales Market to 2027 - Global Analysis and Forecasts by Type (Immun โฆ
BCG Vaccines or Bacillus Calmette Guerin Vaccine intends to prevent from various forms of tuberculosis such as TB meningitis and military in children and adults.
The BCG Vaccines Sales Market is anticipated to grow in the forecast period owing to driving factors such as rising prevalence of tuberculosis, increasing focus of government on immunization programs, and technological advancements. Nevertheless, side effects of the vaccine and global lack of BCG vaccine isโฆ
BCG Vaccine Market Analysis 2023: Merck & Co., Inc., Sanofi Pasteur, Japan BCG L โฆ
Bacillus Calmette-Gurin (BCG) vaccine is the only vaccine currently available for prevention of tuberculosis (TB). One dose of BCG vaccine is recommended for healthy babies at birth in countries where tuberculosis is common.
The major factor that contributes to the market growth are increase in incidence rate of tuberculosis in developing nations, rise in R&D activities related to vaccines, and growth in government initiatives and focus on immunization programs globally.
Getโฆ